BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND B2M, P61769, 567, ENSG00000166710 AND Treatment
17 results:

  • 1. Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.
    Katsuya Y; Yoshida T; Takashima A; Yonemori K; Ohba A; Yazaki S; Yagishita S; Nakahama H; Kobayashi O; Yanagida M; Irino Y; Hamada A; Yamamoto N
    Int J Clin Oncol; 2024 Apr; 29(4):386-397. PubMed ID: 38381163
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for treatment of pancreatic Insulinoma.
    Crinò SF; Napoleon B; Facciorusso A; Lakhtakia S; Borbath I; Caillol F; Do-Cong Pham K; Rizzatti G; Forti E; Palazzo L; Belle A; Vilmann P; van Laethem JL; Mohamadnejad M; Godat S; Hindryckx P; Benson A; Tacelli M; De Nucci G; Binda C; Kovacevic B; Jacob H; Partelli S; Falconi M; Salvia R; Landoni L; ; Larghi A
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2834-2843.e2. PubMed ID: 36871765
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. TGF-β2 antisense oligonucleotide enhances T-cell mediated anti-tumor activities by IL-2 via attenuation of fibrotic reaction in a humanized mouse model of pancreatic ductal adenocarcinoma.
    Lee HK; Nam MW; Go RE; Koo J; Kim TH; Park JE; Choi KC
    Biomed Pharmacother; 2023 Mar; 159():114212. PubMed ID: 36610224
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bariatric surgery reduces the risk of pancreatic cancer in individuals with obesity before the age of 50 years: A nationwide administrative data study in France.
    Bulsei J; Chierici A; Alifano M; Castaldi A; Drai C; De Fatico S; Rosso E; Fontas E; Iannelli A
    Eur J Surg Oncol; 2023 Apr; 49(4):788-793. PubMed ID: 36376141
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation.
    Manuel-Vázquez A; Balakrishnan A; Agami P; Andersson B; Berrevoet F; Besselink MG; Boggi U; Caputo D; Carabias A; Carrion-Alvarez L; Franco CC; Coppola A; Dasari BVM; Diaz-Mercedes S; Feretis M; Fondevila C; Fusai GK; Garcea G; Gonzabay V; Bravo MÁG; Gorris M; Hendrikx B; Hidalgo-Salinas C; Kadam P; Karavias D; Kauffmann E; Kourdouli A; La Vaccara V; van Laarhoven S; Leighton J; Liem MSL; Machairas N; Magouliotis D; Mahmoud A; Marino MV; Massani M; Requena PM; Mentor K; Napoli N; Nijhuis JHT; Nikov A; Nistri C; Nunes V; Ruiz EO; Pandanaboyana S; Saborido BP; Pohnán R; Popa M; Pérez BS; Bueno FS; Serrablo A; Serradilla-Martín M; Skipworth JRA; Soreide K; Symeonidis D; Zacharoulis D; Zelga P; Aliseda D; Santiago MJC; Mancilla CF; Fragua RL; Hughes DL; Llorente CP; Lesurtel M; Gallagher T; Ramia JM;
    Langenbecks Arch Surg; 2022 Dec; 407(8):3447-3455. PubMed ID: 36198881
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Minimally invasive enucleation for benign and low-grade malignant pancreatic tumors: an analysis of 60 cases].
    Liu MQ; Liu WS; Li Z; Zhuo QF; Ji SR; Xu WY; Shi YH; Yu XJ; Xu XW
    Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):674-679. PubMed ID: 35775260
    [No Abstract]    [Full Text] [Related]  

  • 8. [Comparative clinical efficacy analysis of pancreatoduodenectomy for distal bile duct and pancreatic head cancer: a report of 1 005 cases].
    Wu PF; Zhang K; Lu ZP; Lin JZ; Chen JM; Xi CH; Wei JS; Guo F; Tu M; Jiang KR; Miao Y
    Zhonghua Wai Ke Za Zhi; 2022 Feb; 60(2):128-133. PubMed ID: 35012271
    [No Abstract]    [Full Text] [Related]  

  • 9. treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    Langenbecks Arch Surg; 2022 Mar; 407(2):699-706. PubMed ID: 34741671
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The pancreatic cancer Action Network (PanCAN) online patient registry experience.
    Gupta A; Khalid O; Moravek C; Lamkin A; Matrisian LM; Doss S; Denlinger CS; Coveler AL; Weekes CD; Roeland EJ; Hendifar AE; Nipp RD
    Cancer Med; 2021 Oct; 10(20):7152-7161. PubMed ID: 34477302
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic pancreatic cancer That Progressed After Gemcitabine (SEQUOIA).
    Hecht JR; Lonardi S; Bendell J; Sim HW; Macarulla T; Lopez CD; Van Cutsem E; Muñoz Martin AJ; Park JO; Greil R; Wang H; Hozak RR; Gueorguieva I; Lin Y; Rao S; Ryoo BY
    J Clin Oncol; 2021 Apr; 39(10):1108-1118. PubMed ID: 33555926
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma.
    Fang JH; Xu L; Shang LR; Pan CZ; Ding J; Tang YQ; Liu H; Liu CX; Zheng JL; Zhang YJ; Zhou ZG; Xu J; Zheng L; Chen MS; Zhuang SM
    Hepatology; 2019 Sep; 70(3):824-839. PubMed ID: 30506570
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The expression and phosphorylation of ezrin and merlin in human pancreatic cancer.
    Zhou J; Feng Y; Tao K; Su Z; Yu X; Zheng J; Zhang L; Yang D
    Int J Oncol; 2014 Jun; 44(6):2059-67. PubMed ID: 24728215
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells.
    Booy S; van Eijck CH; Dogan F; van Koetsveld PM; Hofland LJ
    J Cell Mol Med; 2014 Mar; 18(3):492-502. PubMed ID: 24460759
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
    Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A randomized trial of the effect of patient race on physicians' intensive care unit and life-sustaining treatment decisions for an acutely unstable elder with end-stage cancer.
    Barnato AE; Mohan D; Downs J; Bryce CL; Angus DC; Arnold RM
    Crit Care Med; 2011 Jul; 39(7):1663-9. PubMed ID: 21460710
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: comparison between non-, early and late recurrence.
    Hsu HP; Shan YS; Hsieh YH; Yang TM; Lin PW
    J Formos Med Assoc; 2007 Jun; 106(6):432-43. PubMed ID: 17588836
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.